1 Market Overview 1.1 Product Overview and Scope of Pharma 4.0 1.2 Classification of Pharma 4.0 by Type 1.2.1 Overview: Global Pharma 4.0 Market Size by Type: 2017 Versus 2021 Versus 2028 1.2.2 Global Pharma 4.0 Revenue Market Share by Type in 2021 1.2.3 Cloud 1.2.4 On-premise 1.3 Global Pharma 4.0 Market by Application 1.3.1 Overview: Global Pharma 4.0 Market Size by Application: 2017 Versus 2021 Versus 2028 1.3.2 Pharmaceutical Industry 1.3.3 IoT Industry 1.3.4 Medical Equipment Industry 1.3.5 Others 1.4 Global Pharma 4.0 Market Size & Forecast 1.5 Global Pharma 4.0 Market Size and Forecast by Region 1.5.1 Global Pharma 4.0 Market Size by Region: 2017 VS 2021 VS 2028 1.5.2 Global Pharma 4.0 Market Size by Region, (2017-2022) 1.5.3 North America Pharma 4.0 Market Size and Prospect (2017-2028) 1.5.4 Europe Pharma 4.0 Market Size and Prospect (2017-2028) 1.5.5 Asia-Pacific Pharma 4.0 Market Size and Prospect (2017-2028) 1.5.6 South America Pharma 4.0 Market Size and Prospect (2017-2028) 1.5.7 Middle East and Africa Pharma 4.0 Market Size and Prospect (2017-2028) 1.6 Market Drivers, Restraints and Trends 1.6.1 Pharma 4.0 Market Drivers 1.6.2 Pharma 4.0 Market Restraints 1.6.3 Pharma 4.0 Trends Analysis 2 Company Profiles 2.1 Pfizer Inc 2.1.1 Pfizer Inc Details 2.1.2 Pfizer Inc Major Business 2.1.3 Pfizer Inc Pharma 4.0 Product and Solutions 2.1.4 Pfizer Inc Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.1.5 Pfizer Inc Recent Developments and Future Plans 2.2 Abbott Laboratories 2.2.1 Abbott Laboratories Details 2.2.2 Abbott Laboratories Major Business 2.2.3 Abbott Laboratories Pharma 4.0 Product and Solutions 2.2.4 Abbott Laboratories Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.2.5 Abbott Laboratories Recent Developments and Future Plans 2.3 GE Healthcare 2.3.1 GE Healthcare Details 2.3.2 GE Healthcare Major Business 2.3.3 GE Healthcare Pharma 4.0 Product and Solutions 2.3.4 GE Healthcare Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.3.5 GE Healthcare Recent Developments and Future Plans 2.4 Boston Scientific 2.4.1 Boston Scientific Details 2.4.2 Boston Scientific Major Business 2.4.3 Boston Scientific Pharma 4.0 Product and Solutions 2.4.4 Boston Scientific Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.4.5 Boston Scientific Recent Developments and Future Plans 2.5 Medtronic Plc. 2.5.1 Medtronic Plc. Details 2.5.2 Medtronic Plc. Major Business 2.5.3 Medtronic Plc. Pharma 4.0 Product and Solutions 2.5.4 Medtronic Plc. Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.5.5 Medtronic Plc. Recent Developments and Future Plans 2.6 Lonza Group AG 2.6.1 Lonza Group AG Details 2.6.2 Lonza Group AG Major Business 2.6.3 Lonza Group AG Pharma 4.0 Product and Solutions 2.6.4 Lonza Group AG Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.6.5 Lonza Group AG Recent Developments and Future Plans 2.7 GlaxoSmithKline plc. 2.7.1 GlaxoSmithKline plc. Details 2.7.2 GlaxoSmithKline plc. Major Business 2.7.3 GlaxoSmithKline plc. Pharma 4.0 Product and Solutions 2.7.4 GlaxoSmithKline plc. Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.7.5 GlaxoSmithKline plc. Recent Developments and Future Plans 2.8 Koninklijke Philips N.V. 2.8.1 Koninklijke Philips N.V. Details 2.8.2 Koninklijke Philips N.V. Major Business 2.8.3 Koninklijke Philips N.V. Pharma 4.0 Product and Solutions 2.8.4 Koninklijke Philips N.V. Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.8.5 Koninklijke Philips N.V. Recent Developments and Future Plans 2.9 Glatt GmbH 2.9.1 Glatt GmbH Details 2.9.2 Glatt GmbH Major Business 2.9.3 Glatt GmbH Pharma 4.0 Product and Solutions 2.9.4 Glatt GmbH Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.9.5 Glatt GmbH Recent Developments and Future Plans 2.10 Vertex 2.10.1 Vertex Details 2.10.2 Vertex Major Business 2.10.3 Vertex Pharma 4.0 Product and Solutions 2.10.4 Vertex Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.10.5 Vertex Recent Developments and Future Plans 2.11 Johnson & Johnson 2.11.1 Johnson & Johnson Details 2.11.2 Johnson & Johnson Major Business 2.11.3 Johnson & Johnson Pharma 4.0 Product and Solutions 2.11.4 Johnson & Johnson Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.11.5 Johnson & Johnson Recent Developments and Future Plans 2.12 Goodly Innovations 2.12.1 Goodly Innovations Details 2.12.2 Goodly Innovations Major Business 2.12.3 Goodly Innovations Pharma 4.0 Product and Solutions 2.12.4 Goodly Innovations Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.12.5 Goodly Innovations Recent Developments and Future Plans 2.13 QbDVision 2.13.1 QbDVision Details 2.13.2 QbDVision Major Business 2.13.3 QbDVision Pharma 4.0 Product and Solutions 2.13.4 QbDVision Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.13.5 QbDVision Recent Developments and Future Plans 2.14 Electrosan 2.14.1 Electrosan Details 2.14.2 Electrosan Major Business 2.14.3 Electrosan Pharma 4.0 Product and Solutions 2.14.4 Electrosan Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.14.5 Electrosan Recent Developments and Future Plans 2.15 GoSilico 2.15.1 GoSilico Details 2.15.2 GoSilico Major Business 2.15.3 GoSilico Pharma 4.0 Product and Solutions 2.15.4 GoSilico Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.15.5 GoSilico Recent Developments and Future Plans 2.16 Smart Factory 2.16.1 Smart Factory Details 2.16.2 Smart Factory Major Business 2.16.3 Smart Factory Pharma 4.0 Product and Solutions 2.16.4 Smart Factory Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.16.5 Smart Factory Recent Developments and Future Plans 3 Market Competition, by Players 3.1 Global Pharma 4.0 Revenue and Share by Players (2019, 2020, 2021, and 2022) 3.2 Market Concentration Rate 3.2.1 Top 3 Pharma 4.0 Players Market Share in 2021 3.2.2 Top 10 Pharma 4.0 Players Market Share in 2021 3.2.3 Market Competition Trend 3.3 Pharma 4.0 Players Head Office, Products and Services Provided 3.4 Pharma 4.0 Mergers & Acquisitions 3.5 Pharma 4.0 New Entrants and Expansion Plans 4 Market Size Segment by Type 4.1 Global Pharma 4.0 Revenue and Market Share by Type (2017-2022) 4.2 Global Pharma 4.0 Market Forecast by Type (2023-2028) 5 Market Size Segment by Application 5.1 Global Pharma 4.0 Revenue Market Share by Application (2017-2022) 5.2 Global Pharma 4.0 Market Forecast by Application (2023-2028) 6 North America by Country, by Type, and by Application 6.1 North America Pharma 4.0 Revenue by Type (2017-2028) 6.2 North America Pharma 4.0 Revenue by Application (2017-2028) 6.3 North America Pharma 4.0 Market Size by Country 6.3.1 North America Pharma 4.0 Revenue by Country (2017-2028) 6.3.2 United States Pharma 4.0 Market Size and Forecast (2017-2028) 6.3.3 Canada Pharma 4.0 Market Size and Forecast (2017-2028) 6.3.4 Mexico Pharma 4.0 Market Size and Forecast (2017-2028) 7 Europe by Country, by Type, and by Application 7.1 Europe Pharma 4.0 Revenue by Type (2017-2028) 7.2 Europe Pharma 4.0 Revenue by Application (2017-2028) 7.3 Europe Pharma 4.0 Market Size by Country 7.3.1 Europe Pharma 4.0 Revenue by Country (2017-2028) 7.3.2 Germany Pharma 4.0 Market Size and Forecast (2017-2028) 7.3.3 France Pharma 4.0 Market Size and Forecast (2017-2028) 7.3.4 United Kingdom Pharma 4.0 Market Size and Forecast (2017-2028) 7.3.5 Russia Pharma 4.0 Market Size and Forecast (2017-2028) 7.3.6 Italy Pharma 4.0 Market Size and Forecast (2017-2028) 8 Asia-Pacific by Region, by Type, and by Application 8.1 Asia-Pacific Pharma 4.0 Revenue by Type (2017-2028) 8.2 Asia-Pacific Pharma 4.0 Revenue by Application (2017-2028) 8.3 Asia-Pacific Pharma 4.0 Market Size by Region 8.3.1 Asia-Pacific Pharma 4.0 Revenue by Region (2017-2028) 8.3.2 China Pharma 4.0 Market Size and Forecast (2017-2028) 8.3.3 Japan Pharma 4.0 Market Size and Forecast (2017-2028) 8.3.4 South Korea Pharma 4.0 Market Size and Forecast (2017-2028) 8.3.5 India Pharma 4.0 Market Size and Forecast (2017-2028) 8.3.6 Southeast Asia Pharma 4.0 Market Size and Forecast (2017-2028) 8.3.7 Australia Pharma 4.0 Market Size and Forecast (2017-2028) 9 South America by Country, by Type, and by Application 9.1 South America Pharma 4.0 Revenue by Type (2017-2028) 9.2 South America Pharma 4.0 Revenue by Application (2017-2028) 9.3 South America Pharma 4.0 Market Size by Country 9.3.1 South America Pharma 4.0 Revenue by Country (2017-2028) 9.3.2 Brazil Pharma 4.0 Market Size and Forecast (2017-2028) 9.3.3 Argentina Pharma 4.0 Market Size and Forecast (2017-2028) 10 Middle East & Africa by Country, by Type, and by Application 10.1 Middle East & Africa Pharma 4.0 Revenue by Type (2017-2028) 10.2 Middle East & Africa Pharma 4.0 Revenue by Application (2017-2028) 10.3 Middle East & Africa Pharma 4.0 Market Size by Country 10.3.1 Middle East & Africa Pharma 4.0 Revenue by Country (2017-2028) 10.3.2 Turkey Pharma 4.0 Market Size and Forecast (2017-2028) 10.3.3 Saudi Arabia Pharma 4.0 Market Size and Forecast (2017-2028) 10.3.4 UAE Pharma 4.0 Market Size and Forecast (2017-2028) 11 Research Findings and Conclusion 12 Appendix 12.1 Methodology 12.2 Research Process and Data Source 12.3 Disclaimer

List of Tables Table 1. Global Pharma 4.0 Revenue by Type, (USD Million), 2017 VS 2021 VS 2028 Table 2. Global Pharma 4.0 Revenue by Application, (USD Million), 2017 VS 2021 VS 2028 Table 3. Global Market Pharma 4.0 Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028) Table 4. Global Pharma 4.0 Revenue (USD Million) by Region (2017-2022) Table 5. Global Pharma 4.0 Revenue Market Share by Region (2023-2028) Table 6. Pfizer Inc Corporate Information, Head Office, and Major Competitors Table 7. Pfizer Inc Major Business Table 8. Pfizer Inc Pharma 4.0 Product and Solutions Table 9. Pfizer Inc Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 10. Abbott Laboratories Corporate Information, Head Office, and Major Competitors Table 11. Abbott Laboratories Major Business Table 12. Abbott Laboratories Pharma 4.0 Product and Solutions Table 13. Abbott Laboratories Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 14. GE Healthcare Corporate Information, Head Office, and Major Competitors Table 15. GE Healthcare Major Business Table 16. GE Healthcare Pharma 4.0 Product and Solutions Table 17. GE Healthcare Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 18. Boston Scientific Corporate Information, Head Office, and Major Competitors Table 19. Boston Scientific Major Business Table 20. Boston Scientific Pharma 4.0 Product and Solutions Table 21. Boston Scientific Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 22. Medtronic Plc. Corporate Information, Head Office, and Major Competitors Table 23. Medtronic Plc. Major Business Table 24. Medtronic Plc. Pharma 4.0 Product and Solutions Table 25. Medtronic Plc. Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 26. Lonza Group AG Corporate Information, Head Office, and Major Competitors Table 27. Lonza Group AG Major Business Table 28. Lonza Group AG Pharma 4.0 Product and Solutions Table 29. Lonza Group AG Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 30. GlaxoSmithKline plc. Corporate Information, Head Office, and Major Competitors Table 31. GlaxoSmithKline plc. Major Business Table 32. GlaxoSmithKline plc. Pharma 4.0 Product and Solutions Table 33. GlaxoSmithKline plc. Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 34. Koninklijke Philips N.V. Corporate Information, Head Office, and Major Competitors Table 35. Koninklijke Philips N.V. Major Business Table 36. Koninklijke Philips N.V. Pharma 4.0 Product and Solutions Table 37. Koninklijke Philips N.V. Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 38. Glatt GmbH Corporate Information, Head Office, and Major Competitors Table 39. Glatt GmbH Major Business Table 40. Glatt GmbH Pharma 4.0 Product and Solutions Table 41. Glatt GmbH Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 42. Vertex Corporate Information, Head Office, and Major Competitors Table 43. Vertex Major Business Table 44. Vertex Pharma 4.0 Product and Solutions Table 45. Vertex Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 46. Johnson & Johnson Corporate Information, Head Office, and Major Competitors Table 47. Johnson & Johnson Major Business Table 48. Johnson & Johnson Pharma 4.0 Product and Solutions Table 49. Johnson & Johnson Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 50. Goodly Innovations Corporate Information, Head Office, and Major Competitors Table 51. Goodly Innovations Major Business Table 52. Goodly Innovations Pharma 4.0 Product and Solutions Table 53. Goodly Innovations Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 54. QbDVision Corporate Information, Head Office, and Major Competitors Table 55. QbDVision Major Business Table 56. QbDVision Pharma 4.0 Product and Solutions Table 57. QbDVision Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 58. Electrosan Corporate Information, Head Office, and Major Competitors Table 59. Electrosan Major Business Table 60. Electrosan Pharma 4.0 Product and Solutions Table 61. Electrosan Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 62. GoSilico Corporate Information, Head Office, and Major Competitors Table 63. GoSilico Major Business Table 64. GoSilico Pharma 4.0 Product and Solutions Table 65. GoSilico Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 66. Smart Factory Corporate Information, Head Office, and Major Competitors Table 67. Smart Factory Major Business Table 68. Smart Factory Pharma 4.0 Product and Solutions Table 69. Smart Factory Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 70. Global Pharma 4.0 Revenue (USD Million) by Players (2019, 2020, 2021, and 2022) Table 71. Global Pharma 4.0 Revenue Share by Players (2019, 2020, 2021, and 2022) Table 72. Breakdown of Pharma 4.0 by Company Type (Tier 1, Tier 2 and Tier 3) Table 73. Pharma 4.0 Players Head Office, Products and Services Provided Table 74. Pharma 4.0 Mergers & Acquisitions in the Past Five Years Table 75. Pharma 4.0 New Entrants and Expansion Plans Table 76. Global Pharma 4.0 Revenue (USD Million) by Type (2017-2022) Table 77. Global Pharma 4.0 Revenue Share by Type (2017-2022) Table 78. Global Pharma 4.0 Revenue Forecast by Type (2023-2028) Table 79. Global Pharma 4.0 Revenue by Application (2017-2022) Table 80. Global Pharma 4.0 Revenue Forecast by Application (2023-2028) Table 81. North America Pharma 4.0 Revenue by Type (2017-2022) & (USD Million) Table 82. North America Pharma 4.0 Revenue by Type (2023-2028) & (USD Million) Table 83. North America Pharma 4.0 Revenue by Application (2017-2022) & (USD Million) Table 84. North America Pharma 4.0 Revenue by Application (2023-2028) & (USD Million) Table 85. North America Pharma 4.0 Revenue by Country (2017-2022) & (USD Million) Table 86. North America Pharma 4.0 Revenue by Country (2023-2028) & (USD Million) Table 87. Europe Pharma 4.0 Revenue by Type (2017-2022) & (USD Million) Table 88. Europe Pharma 4.0 Revenue by Type (2023-2028) & (USD Million) Table 89. Europe Pharma 4.0 Revenue by Application (2017-2022) & (USD Million) Table 90. Europe Pharma 4.0 Revenue by Application (2023-2028) & (USD Million) Table 91. Europe Pharma 4.0 Revenue by Country (2017-2022) & (USD Million) Table 92. Europe Pharma 4.0 Revenue by Country (2023-2028) & (USD Million) Table 93. Asia-Pacific Pharma 4.0 Revenue by Type (2017-2022) & (USD Million) Table 94. Asia-Pacific Pharma 4.0 Revenue by Type (2023-2028) & (USD Million) Table 95. Asia-Pacific Pharma 4.0 Revenue by Application (2017-2022) & (USD Million) Table 96. Asia-Pacific Pharma 4.0 Revenue by Application (2023-2028) & (USD Million) Table 97. Asia-Pacific Pharma 4.0 Revenue by Region (2017-2022) & (USD Million) Table 98. Asia-Pacific Pharma 4.0 Revenue by Region (2023-2028) & (USD Million) Table 99. South America Pharma 4.0 Revenue by Type (2017-2022) & (USD Million) Table 100. South America Pharma 4.0 Revenue by Type (2023-2028) & (USD Million) Table 101. South America Pharma 4.0 Revenue by Application (2017-2022) & (USD Million) Table 102. South America Pharma 4.0 Revenue by Application (2023-2028) & (USD Million) Table 103. South America Pharma 4.0 Revenue by Country (2017-2022) & (USD Million) Table 104. South America Pharma 4.0 Revenue by Country (2023-2028) & (USD Million) Table 105. Middle East & Africa Pharma 4.0 Revenue by Type (2017-2022) & (USD Million) Table 106. Middle East & Africa Pharma 4.0 Revenue by Type (2023-2028) & (USD Million) Table 107. Middle East & Africa Pharma 4.0 Revenue by Application (2017-2022) & (USD Million) Table 108. Middle East & Africa Pharma 4.0 Revenue by Application (2023-2028) & (USD Million) Table 109. Middle East & Africa Pharma 4.0 Revenue by Country (2017-2022) & (USD Million) Table 110. Middle East & Africa Pharma 4.0 Revenue by Country (2023-2028) & (USD Million) List of Figures Figure 1. Pharma 4.0 Picture Figure 2. Global Pharma 4.0 Revenue Market Share by Type in 2021 Figure 3. Cloud Figure 4. On-premise Figure 5. Pharma 4.0 Revenue Market Share by Application in 2021 Figure 6. Pharmaceutical Industry Picture Figure 7. IoT Industry Picture Figure 8. Medical Equipment Industry Picture Figure 9. Others Picture Figure 10. Global Pharma 4.0 Market Size, (USD Million): 2017 VS 2021 VS 2028 Figure 11. Global Pharma 4.0 Revenue and Forecast (2017-2028) & (USD Million) Figure 12. Global Pharma 4.0 Revenue Market Share by Region (2017-2028) Figure 13. Global Pharma 4.0 Revenue Market Share by Region in 2021 Figure 14. North America Pharma 4.0 Revenue (USD Million) and Growth Rate (2017-2028) Figure 15. Europe Pharma 4.0 Revenue (USD Million) and Growth Rate (2017-2028) Figure 16. Asia-Pacific Pharma 4.0 Revenue (USD Million) and Growth Rate (2017-2028) Figure 17. South America Pharma 4.0 Revenue (USD Million) and Growth Rate (2017-2028) Figure 18. Middle East and Africa Pharma 4.0 Revenue (USD Million) and Growth Rate (2017-2028) Figure 19. Pharma 4.0 Market Drivers Figure 20. Pharma 4.0 Market Restraints Figure 21. Pharma 4.0 Market Trends Figure 22. Pfizer Inc Recent Developments and Future Plans Figure 23. Abbott Laboratories Recent Developments and Future Plans Figure 24. GE Healthcare Recent Developments and Future Plans Figure 25. Boston Scientific Recent Developments and Future Plans Figure 26. Medtronic Plc. Recent Developments and Future Plans Figure 27. Lonza Group AG Recent Developments and Future Plans Figure 28. GlaxoSmithKline plc. Recent Developments and Future Plans Figure 29. Koninklijke Philips N.V. Recent Developments and Future Plans Figure 30. Glatt GmbH Recent Developments and Future Plans Figure 31. Vertex Recent Developments and Future Plans Figure 32. Johnson & Johnson Recent Developments and Future Plans Figure 33. Goodly Innovations Recent Developments and Future Plans Figure 34. QbDVision Recent Developments and Future Plans Figure 35. Electrosan Recent Developments and Future Plans Figure 36. GoSilico Recent Developments and Future Plans Figure 37. Smart Factory Recent Developments and Future Plans Figure 38. Global Pharma 4.0 Revenue Share by Players in 2021 Figure 39. Pharma 4.0 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021 Figure 40. Global Top 3 Players Pharma 4.0 Revenue Market Share in 2021 Figure 41. Global Top 10 Players Pharma 4.0 Revenue Market Share in 2021 Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022) Figure 43. Global Pharma 4.0 Revenue Share by Type in 2021 Figure 44. Global Pharma 4.0 Market Share Forecast by Type (2023-2028) Figure 45. Global Pharma 4.0 Revenue Share by Application in 2021 Figure 46. Global Pharma 4.0 Market Share Forecast by Application (2023-2028) Figure 47. North America Pharma 4.0 Sales Market Share by Type (2017-2028) Figure 48. North America Pharma 4.0 Sales Market Share by Application (2017-2028) Figure 49. North America Pharma 4.0 Revenue Market Share by Country (2017-2028) Figure 50. United States Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million) Figure 51. Canada Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million) Figure 52. Mexico Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million) Figure 53. Europe Pharma 4.0 Sales Market Share by Type (2017-2028) Figure 54. Europe Pharma 4.0 Sales Market Share by Application (2017-2028) Figure 55. Europe Pharma 4.0 Revenue Market Share by Country (2017-2028) Figure 56. Germany Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million) Figure 57. France Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million) Figure 58. United Kingdom Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million) Figure 59. Russia Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million) Figure 60. Italy Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million) Figure 61. Asia-Pacific Pharma 4.0 Sales Market Share by Type (2017-2028) Figure 62. Asia-Pacific Pharma 4.0 Sales Market Share by Application (2017-2028) Figure 63. Asia-Pacific Pharma 4.0 Revenue Market Share by Region (2017-2028) Figure 64. China Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million) Figure 65. Japan Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million) Figure 66. South Korea Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million) Figure 67. India Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million) Figure 68. Southeast Asia Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million) Figure 69. Australia Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million) Figure 70. South America Pharma 4.0 Sales Market Share by Type (2017-2028) Figure 71. South America Pharma 4.0 Sales Market Share by Application (2017-2028) Figure 72. South America Pharma 4.0 Revenue Market Share by Country (2017-2028) Figure 73. Brazil Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million) Figure 74. Argentina Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million) Figure 75. Middle East and Africa Pharma 4.0 Sales Market Share by Type (2017-2028) Figure 76. Middle East and Africa Pharma 4.0 Sales Market Share by Application (2017-2028) Figure 77. Middle East and Africa Pharma 4.0 Revenue Market Share by Country (2017-2028) Figure 78. Turkey Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million) Figure 79. Saudi Arabia Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million) Figure 80. UAE Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million) Figure 81. Methodology Figure 82. Research Process and Data Source

Pfizer Inc Abbott Laboratories GE Healthcare Boston Scientific Medtronic Plc. Lonza Group AG GlaxoSmithKline plc. Koninklijke Philips N.V. Glatt GmbH Vertex Johnson & Johnson Goodly Innovations QbDVision Electrosan GoSilico Smart Factory